Tech boss funds project to make military dogs smell and see better

Palmer Luckey’s newest venture, Warhound, has secured $200 million in funding to create genetically enhanced dogs for military use. The startup announced the capital raise on 23 October 2026, marking a major investment in the intersection of biotechnology and defense operations.

The company intends to use the funds to develop canines with heightened sensory capabilities. According to reports, the dogs will be engineered to detect explosives more effectively and provide improved protection for troops. This approach moves beyond traditional training methods by altering the animals' biological traits at the genetic level.

Sequoia Capital is listed among the investors who contributed to the round. Warhound is collaborating with Colossal Biosciences to handle the technical aspects of the project. The biotech firm is assisting with both the cloning processes and the specific gene-editing techniques required to modify the animals' DNA.

The move places a well-known tech figure at the center of a new defense initiative. Luckey, who previously founded Oculus, is now leading a company that aims to redefine the role of service animals in combat scenarios. The partnership with Colossal Biosciences brings specialized expertise in genetic modification to the project.

The financial backing signals strong investor interest in applying biotech solutions to military needs. The $200 million injection will support research and development efforts over the coming years. Investors are betting that engineered animals can offer a distinct advantage in detecting threats on the battlefield.

The project raises questions about the future of military assets. By combining advanced gene editing with traditional animal service, Warhound is exploring a new path for defense technology. The collaboration focuses on creating animals that can perform critical tasks with greater precision than their unmodified counterparts.

Warhound stated that its primary goal is to improve safety for military personnel. The company plans to utilize the raised capital to advance its research and begin the development of the first generation of these enhanced canines.